RMD Resmed Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RMD

Price (delayed)

$183.42

Market cap

$26.98B

P/E Ratio

30.27

Dividend/share

$1.88

EPS

$6.06

Enterprise value

$28.16B

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea , chronic obstructive pulmonary disease , and other respiratory ...

Highlights
The price to earnings (P/E) is 34% lower than the 5-year quarterly average of 46.2 and 3.3% lower than the last 4 quarters average of 31.3
Resmed's debt has decreased by 28% YoY and by 7% QoQ
Resmed's quick ratio has increased by 5% from the previous quarter but it has decreased by 2.4% YoY
Resmed's gross margin has decreased by 2.8% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.resmed.com/
Peers: MDT TMO ELMD MASI

Key stats

What are the main financial stats of RMD
Market
Shares outstanding
147.09M
Market cap
$26.98B
Enterprise value
$28.16B
Valuations
Price to earnings (P/E)
30.27
Price to book (P/B)
6.02
Price to sales (P/S)
5.99
EV/EBIT
24.35
EV/EBITDA
20.54
EV/Sales
6.25
Earnings
Revenue
$4.5B
EBIT
$1.16B
EBITDA
$1.37B
Free cash flow
$962.46M
Per share
EPS
$6.06
Free cash flow per share
$6.54
Book value per share
$30.47
Revenue per share
$30.61
TBVPS
$23.89
Balance sheet
Total assets
$6.91B
Total liabilities
$2.42B
Debt
$1.39B
Equity
$4.48B
Working capital
$1.61B
Liquidity
Debt to equity
0.31
Current ratio
3.11
Quick ratio
1.23
Net debt/EBITDA
0.86
Margins
EBITDA margin
30.4%
Gross margin
55.1%
Net margin
19.8%
Operating margin
25.3%
Efficiency
Return on assets
13.1%
Return on equity
21.2%
Return on invested capital
29%
Return on capital employed
18.8%
Return on sales
25.7%
Dividend
Dividend yield
1.02%
DPS
$1.88
Payout ratio
31%

RMD stock price

How has the Resmed stock price performed over time
Intraday
-0.2%
1 week
3.27%
1 month
-5.12%
1 year
-19.06%
YTD
6.63%
QTD
-7.38%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$4.5B
Gross profit
$2.48B
Operating income
$1.14B
Net income
$890.39M
Gross margin
55.1%
Net margin
19.8%
The company's revenue rose by 20% YoY and by 2.9% QoQ
The gross profit has grown by 16% YoY and by 2.8% from the previous quarter
RMD's net income is up by 10% YoY
RMD's operating income is up by 9% YoY

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
RMD P/E details
P/E
30.27
P/B
6.02
P/S
5.99
EV/EBIT
24.35
EV/EBITDA
20.54
EV/Sales
6.25
The price to earnings (P/E) is 34% lower than the 5-year quarterly average of 46.2 and 3.3% lower than the last 4 quarters average of 31.3
The EPS has increased by 10% YoY
RMD's P/B is 37% below its 5-year quarterly average of 9.5 and 10% below its last 4 quarters average of 6.7
RMD's equity is up by 20% year-on-year and by 5% since the previous quarter
The P/S is 30% lower than the 5-year quarterly average of 8.5 and 8% lower than the last 4 quarters average of 6.5
The company's revenue rose by 20% YoY and by 2.9% QoQ

Efficiency

How efficient is Resmed business performance
The company's return on invested capital fell by 12% YoY
The ROA has decreased by 11% YoY and by 3% from the previous quarter
Resmed's ROE has decreased by 9% YoY and by 6% from the previous quarter
The ROS has decreased by 6% YoY and by 3.7% from the previous quarter

Dividends

What is RMD's dividend history
Dividend details
DPS
$1.88
Dividend yield
1.02%
Payout ratio
31%
Recent dividends

Financial health

How did Resmed financials performed over time
The company's total assets is 185% higher than its total liabilities
RMD's total liabilities is down by 18% year-on-year and by 2.7% since the previous quarter
Resmed's quick ratio has increased by 5% from the previous quarter but it has decreased by 2.4% YoY
Resmed's debt is 69% lower than its equity
Resmed's debt to equity has decreased by 40% YoY and by 11% QoQ
Resmed's debt has decreased by 28% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.